Paul has had an extensive career in the pharmaceutical industry having been President of Novo Nordisk France for 15 years and before that working as a Marketing Director for seven years at Abbot France and Boots, both in the UK and France. In 1994, Paul set up his own pharmaceutical company, Laboratoires Murat, which was purchased by Fuisz Technologies Ltd, a Nasdaq listed drug delivery company, three years later. Paul then worked as Executive Vice President, Operations for Fuisz Technologies in Paris before he sold the business to Shire plc in 1999 for a further premium. In 2007, Paul became a controlling shareholder and Director of US listed IVAX Diagnostics, Inc, which was subsequently sold to Transasia Bio-Medicals Ltd, India’s largest in-vitro diagnostics company, in September 2010. Paul was a non-executive director of Venn Life Sciences Holdings from March 2013 until his resignation upon Admission.
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes